Literature DB >> 18329207

Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.

Naoki Uramoto1, Mitsuru Furukawa, Tomokazu Yoshizaki.   

Abstract

The majority of the oncogenic osteomalacia-associated mesenchymal tumors are considered to belong to the category of phosphaturic mesenchymal tumors, mixed connective tissue (PMTMCT) variant, of which malignant cases are very rare. Here we report a case of a recurrent malignant PMTMCT variant which arose in the tongue. The patient was treated with surgery at an initial treatment and the first recurrence. In accordance with the tumor recurrence and resection, the hypophosphatemia progressed and improved. However, hypophosphatemia did not progress after receiving radiation therapy at the second recurrence even though the recurrent tumor gradually increased its size. These results suggest clinical feature of malignant PMTMCT could be changed by radiation therapy. Thus, this report could add an insight to the nature of PMTMCT.

Entities:  

Mesh:

Year:  2008        PMID: 18329207     DOI: 10.1016/j.anl.2008.01.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  29 in total

1.  Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients.

Authors:  Chi Long Ho
Journal:  Nucl Med Mol Imaging       Date:  2015-03-25

Review 2.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

4.  Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.

Authors:  Jason K Wasserman; Bibianna Purgina; Chi K Lai; Denis Gravel; Alyssa Mahaffey; Diana Bell; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2016-01-12

5.  Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.

Authors:  Valentina D Tarasova; Alejandro G Trepp-Carrasco; Robert Thompson; Robert R Recker; William H Chong; Michael T Collins; Laura A G Armas
Journal:  J Clin Endocrinol Metab       Date:  2013-09-06       Impact factor: 5.958

Review 6.  Tumor-Induced Osteomalacia.

Authors:  Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

Review 7.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

8.  The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Authors:  Cameron K Ledford; Nicole A Zelenski; Diana M Cardona; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2013-07-19       Impact factor: 4.176

9.  Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.

Authors:  Lulu Sun; Carina Dehner; Jason Kenney; Samantha M McNulty; Xiaopei Zhu; John D Pfeifer; Horacio M Maluf; John S A Chrisinger
Journal:  Virchows Arch       Date:  2020-11-05       Impact factor: 4.064

10.  Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour.

Authors:  A R M Radaideh; D Jaradat; M M Abu-Kalaf; M K Nusier
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.